SPATAFORA, Mario
 Distribuzione geografica
Continente #
NA - Nord America 2.725
EU - Europa 909
AS - Asia 213
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
SA - Sud America 2
Totale 3.853
Nazione #
US - Stati Uniti d'America 2.725
IT - Italia 262
CN - Cina 181
UA - Ucraina 179
FI - Finlandia 158
IE - Irlanda 81
GB - Regno Unito 53
DE - Germania 45
RU - Federazione Russa 32
BE - Belgio 31
SE - Svezia 27
FR - Francia 21
IN - India 9
RO - Romania 8
KR - Corea 7
CH - Svizzera 3
HK - Hong Kong 3
AT - Austria 2
GR - Grecia 2
IR - Iran 2
MY - Malesia 2
NL - Olanda 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BG - Bulgaria 1
BR - Brasile 1
CZ - Repubblica Ceca 1
EU - Europa 1
GE - Georgia 1
JP - Giappone 1
KZ - Kazakistan 1
LB - Libano 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PY - Paraguay 1
SG - Singapore 1
TR - Turchia 1
VN - Vietnam 1
Totale 3.853
Città #
Fairfield 459
Woodbridge 256
Chandler 226
Houston 209
Ashburn 208
Seattle 176
Wilmington 176
Cambridge 155
Ann Arbor 114
Jacksonville 101
Dublin 81
Des Moines 80
Medford 66
Palermo 63
Nanjing 43
Princeton 41
Altamura 35
Brussels 31
Tulsa 28
Dearborn 26
Boardman 25
Lawrence 24
San Diego 22
Beijing 20
Changsha 15
Falls Church 14
Hebei 14
Shenyang 14
Jiaxing 12
Nanchang 12
Jinan 9
Kumar 7
Milan 7
Seongnam 7
Cremona 6
Guangzhou 6
Helsinki 6
London 6
Saint Petersburg 6
Tianjin 6
Verona 6
Trapani 5
Zhengzhou 5
Chicago 4
Dallas 4
Kunming 4
Ningbo 4
Atlanta 3
Auburn Hills 3
Central District 3
Düsseldorf 3
Hangzhou 3
Norwalk 3
Phoenix 3
Redwood City 3
Chengdu 2
Den Haag 2
Frankfurt 2
Fuzhou 2
Haikou 2
Mozzo 2
Napoli 2
San Francisco 2
San Genesio Ed Uniti 2
San Mateo 2
San Paolo di Civitate 2
Tehran 2
Walnut 2
Yellow Springs 2
Albenga 1
Almaty 1
Amarillo 1
Arkhangelsk 1
Auckland 1
Aversa 1
Berlin 1
Brentford 1
Brescia 1
Castelvetrano 1
Changchun 1
Chiswick 1
Clearwater 1
Cormeilles-en-Parisis 1
Edinburgh 1
Frankfurt Am Main 1
Hanoi 1
Izhevsk 1
Izmir 1
Kuala Lumpur 1
La Canada Flintridge 1
Lanzhou 1
Los Angeles 1
Media 1
Melbourne 1
Mountain View 1
Mozzate 1
Mumbai 1
New Bedfont 1
Nürnberg 1
Omaha 1
Totale 2.927
Nome #
A 15-year-old boy with anterior chest pain, progressive dyspnea, and subcutaneous emphysema of the neck 168
Are Asthmatics Enrolled in Randomized Trials Representative of Real-Life Outpatients? 168
Effects of extra-fine inhaled beclomethasone/formoterol on both large and small airways in asthma 159
Altered CD94/NKG2A and perforin expression reduce the cytotoxic activity in malignant pleural effusions 152
Asthmatics with high levels of serum surfactant protein D have more severe disease 149
Challenges in the pharmacological treatment of geriatric asthma 147
Asthma in the elderly: A different disease? 142
Use of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmatics 134
Higher serum levels of periostin and the risk of exacerbations in moderate asthmatics 133
Ageing and COPD affect different domains of nutritional status: the ECCE study 130
Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study 127
LTB4 is present in exudative pleural effusions and contributes actively to neutrophil recruitment in the inflamed pleural space 124
Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer 121
Light smoking and dependence symptoms in high-school students 115
Asthma and metabolic syndrome: Current knowledge and future perspectives. 113
Safety Considerations of Inhaled Corticosteroids in the Elderly 112
Blood eosinophils and treatment response in hospitalized exacerbations of chronic obstructive pulmonary disease: A case-control study 111
Lung penetration and patient adherence considerations in the management of asthma: Role of extra-fine formulations 110
Gemcitabine sensitizes lung cancer cells to Fas/FasL system-mediated killing 103
Lung cancer: does age affect treatment strategy ? 102
VEGF is involved in local and systemic aspects of COPD. 96
Questionnaires, spirometry and PEF monitoring in epidemiological studies on elderly respiratory patients 96
Mesotelioma pleurico maligno 93
Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer 91
Correlati delle alterazioni della composizione corporea in pazienti anziani con BPCO 87
The Risk of Malnutrition Correlates with Perception of Dyspnea in COPD 74
null 73
La terapia con broncodilatatori nel paziente anziano 69
Sleep disorders in the elderly with and without chronic airflow obstruction: the SARA study 69
Aging and COPD affect different domains of nutritional status – The ECCE study. 68
Correlates of Energy Expenditure and Sedentary Life in Free-Living COPD. 63
Invecchiamento, stress ossidativo e funzione polmonare 63
Phase I-II trial of gemcitabine-based first-line chemotherapies for small cell lung cancer in elderly patients with performance status 0-2: The G-Step trial 61
Cytotoxic lymphocytes show reduced expression of cd94/NKG2A and perforin in malignant pleural effusions 58
FEV1/FEV6 and FEV6: sensitivity and specificity in detecting obstructive and restrictive disease of older patients 51
Tumori polmonari 49
A mild form of rituximab-associated lung injury in two adolescents treated for nephrotic syndrome 49
Phase III study in patients with stage IV non small cell lung cancer treated with two cycles of cisplatin/gemcitabine followed by a randomization to three additional cycle of the same combination or gemcitabine alone 47
Terapia del carcinoma polmonare non a piccole cellule in stadio IIIA e IIIB a buona prognosi 45
Studio multicentrico di III fase in pazienti affetti da carcinoma polmonare non a piccole cellule in stadio IV non precedentemente chemiotrattati 43
Leptin levels in induced sputum from patients with COPD are sensitive to smoking status 40
Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone. 16
null 3
Totale 4.024
Categoria #
all - tutte 9.266
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.266


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019370 0 0 15 7 2 41 39 6 14 45 97 104
2019/20201.173 125 45 68 117 135 153 138 82 127 51 90 42
2020/2021662 32 57 47 63 60 39 45 43 68 83 58 67
2021/2022465 23 106 12 5 14 22 24 19 47 68 38 87
2022/2023644 60 114 14 69 65 100 68 39 66 12 27 10
2023/202480 13 53 14 0 0 0 0 0 0 0 0 0
Totale 4.024